Fimea to reform its marketing authorisation and medicinal products register

Finnish Medicines Agency Fimea has entered into a contract with Solita for the implementation of a register platform solution and the marketing authorisation and medicinal products register as well as its related services. The solution will be implemented in the hosting service environment that will be acquired from Valtori.

The register platform solution will improve the quality, consistency, usability and scalability of Fimea’s register data. The solution will facilitate more efficient processes and an increase to the level of automation. The solution will contain database, integration and process automation and control services for the implementation of Fimea’s registers.

The first step will be to implement the new marketing authorisation and medicinal products register. The objective will be for the register to form a harmonious and uniform entity on medicinal product data and that it will also serve the needs of Fimea’s stakeholders better than before. At the same time, functionalities that will increase the automation level of processes will be implemented; e.g. links to invoicing.

The objective is for the marketing authorisation and medicinal products register to be adopted at the beginning of 2020.